PNC Financial Services Group
ESLA icon

PNC Financial Services Group’s Estrella Immunopharma ESLA Stock Holding History

PNC Financial Services Group’s Portfolio ESLA Stock Details ESLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-93,375
Closed -$939K – 4790
2022
Q3 		$939K Hold
93,375
– – ﹤0.01% 1159
2022
Q2 		$934K Hold
93,375
– – ﹤0.01% 1194
2022
Q1 		$933K Hold
93,375
– – ﹤0.01% 1275
2021
Q4 		$925K Hold
93,375
– – ﹤0.01% 1331
2021
Q3 		$924K Buy
+93,375
New +$918K ﹤0.01% 1232

Other funds holding ESLA

KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
HHGC
Hunting Hill Global Capital New York $129M AUM 17.34% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PNC Financial Services Group's ESLA Position: Q4 2022 in Review

PNC Financial Services Group sold out of Estrella Immunopharma (ESLA) in Q4 2022, closing a stake of 93,375 shares — an estimated $939K sold.

PNC Financial Services Group first reported a position in ESLA in Q3 2021 and held it in 5 quarters. The position peaked at $939K in Q3 2022. 13 funds tracked by Wall St. Rank hold ESLA as of Q4 2022.

  • PNC Financial Services Group reported no remaining Estrella Immunopharma position as of Q4 2022 after selling out during the quarter.
  • PNC Financial Services Group sold 93,375 Estrella Immunopharma shares in Q4 2022, an estimated $939K.
  • PNC Financial Services Group first reported a position in Estrella Immunopharma in Q3 2021 and held it in 5 quarters.
  • PNC Financial Services Group's Estrella Immunopharma position peaked at $939K in Q3 2022.
  • 13 funds tracked by Wall St. Rank held Estrella Immunopharma as of Q4 2022.

Based on PNC Financial Services Group's 13F filing for Q4 2022, filed 10 Feb 2023.